Intelligent Retinal Imaging Systems, Inc.

Intelligent Retinal Imaging Systems (IRIS) develops cloud-based retinal screening software designed to identify and manage diabetic retinopathy and other retinal pathologies. The company provides a comprehensive solution combining digital retinal imaging capture, image enhancement, remote interpretation by board-certified ophthalmologists, and integration with existing electronic medical records (EMR) systems. IRIS operates a camera-agnostic platform compatible with multiple imaging devices, enabling healthcare providers to conduct preventive retinal screenings in primary care settings, federally qualified health centers (FQHCs), hospitals, health plans, pharmacies, and health risk assessment companies. The platform securely stores and manages patient information, with results delivered to providers within target timeframes. Implementation includes customized workflow integration, staff training, hardware recommendations, and ongoing technical support. The solution is designed for rapid deployment, with typical go-live in 90 days. IRIS serves diverse healthcare organizations including major health systems (Prisma Health, St. Elizabeth Physicians, LifeBridge), health insurance plans, and community care networks. The company emphasizes care gap closure for diabetic patients, reducing preventable blindness, and improving quality compliance measures. As of 2025, Intelligent Retinal Imaging Systems was acquired by Topcon Healthcare to enhance connected care across primary and eye care settings.